- Home
- SIDU vs NTHI Comparison
SIDU vs NTHI Comparison
Compare SIDU & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIDU | NTHI |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.0M | 195.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SIDU | NTHI |
|---|---|---|
| Price | $3.68 | $8.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 97.1M | 66.3K |
| Earning Date | 11-14-2025 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,623,538.00 | $59,990.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.63 | $3.20 |
| 52 Week High | $5.39 | $25.00 |
Technical Indicators
Market Signals| Indicator | SIDU | NTHI |
|---|---|---|
| Relative Strength Index (RSI) | 58.13 | 44.20 |
| Support Level | $2.88 | $8.11 |
| Resistance Level | $4.05 | $10.19 |
| Average True Range (ATR) | 0.85 | 0.86 |
| MACD | -0.09 | -0.04 |
| Stochastic Oscillator | 39.59 | 12.92 |
Price Performance
Historical ComparisonAbout SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).